Natus Medical Forms Global EEG Advisory Board to Guide AI and Clinical Strategy

Natus Medical Incorporated has established a Global EEG Advisory Board to provide strategic guidance on neurodiagnostic innovation, announced in a press release. The board brings together clinical leaders from fields including epilepsy, neurocritical care, pediatric neurology, and clinical neurophysiology.

The advisory group will support Natus in areas such as AI supported EEG interpretation, point of care EEG, and scalable clinical workflows. It will also contribute to the development of clinical evidence and ensure that product innovation aligns with real world patient care.

The U.S. advisory board is chaired by Dr. Brian Litt, a neurologist and professor of Neurology and Bioengineering at the University of Pennsylvania. Members will collaborate with Natus leadership through meetings focused on advancing the next generation of EEG systems, improving workflow efficiency, and expanding the use of AI in clinical decision making.

Insights from the board will inform product design, clinical research programs, and global education initiatives across the company’s neurodiagnostic portfolio.